ARCHIVES

ODAC Votes 13:0 For Approving Perjeta

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Study Opens For Women At Risk of Ovarian Cancer

October 29, 2004

NCI Should Examine Alternative Therapies TA Report Says

September 28, 1990

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006

CMS Final Rule Imposes 6 Percent Cut On Physician Fees Over Four Years

November 6, 2009

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

October 8, 2004

Hydridoma Cell Lines Available

March 5, 1982